ArticleSignal transduction and targeted therapy2020

CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1.

Junjie Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.